Page 2 - Sci Capital News Today

BRISBANE, Calif., Jan. 29, 2024 -- Vera Therapeutics, Inc. , a late clinical-stage biotechnology company developing and commercializing transformative treatments for patients with serious...

NEWTOWN SQUARE, Pa., Jan. 25, 2024 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (“ArriVent”) (Nasdaq: AVBP), a clinical-stage company dedicated to...

– Stephen Mahoney appointed President and Chief Executive Officer – – Potential best-in-class subcutaneous and intravenous thyroid eye disease programs targeting insulin-like growth factor 1...

NEW YORK, Oct. 02, 2023 -- Immunovant, Inc. , a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announced the closing of its...

NEW YORK, Sept. 27, 2023 -- Immunovant, Inc. , a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announced the pricing of an...

SAN DIEGO, Sept. 12, 2023 -- Crinetics Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for...

Pear Therapeutics was once regarded as a digital therapeutics pioneer, but its spiral into bankruptcy has the industry searching for the best path forward. While some favor going direct to consumers, others say the solution is in generating more robust clinical trial data to persuade hesitant payers.

—Combines Three Leading Human Biomimetic Organoid Platform Technologies for Neurological Drug Discovery—

WALTHAM, Mass. and BOULDER, Colo., June 06, 2023 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on...

Trailblazer Merger Corporation I Announces the Separate Trading of ...